Determines disease progression and appropriate treatment course for hepatocellular carcinoma (HCC) patients. The BCLC staging system integrates tumor characteristics, liver function status, and performance status to classify patients into five stages (0, A, B, C, D) with specific treatment recommendations for each stage.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The Barcelona-Clinic Liver Cancer (BCLC) Staging Classification is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Very Early Stage: Single nodule <2cm, PS 0, Child-Pugh A
Early Stage: Single nodule or up to 3 nodules ≤3cm, PS 0, Child-Pugh A-B
Intermediate Stage: Multinodular, PS 0, Child-Pugh A-B
Advanced Stage: Portal invasion or extrahepatic spread, PS 1-2, Child-Pugh A-B
Terminal Stage: Any tumor burden, PS >2 or Child-Pugh C
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.